565 related articles for article (PubMed ID: 20571380)
21. ADHD, methylphenidate and driving: does some legislation endanger public health?
Verster JC; Cox DJ
J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
[No Abstract] [Full Text] [Related]
22. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
23. [Methylphenidate double-blind trial: indication and performing].
Bliznakova L; Gerstner S; Schmidt MH; Becker K
Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
[TBL] [Abstract][Full Text] [Related]
24. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
Ghanizadeh A
Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
[No Abstract] [Full Text] [Related]
25. [Methylphenidate induced ST elevation acute myocardial infarction].
Ruwald MH; Ruwald AC; Tønder N
Ugeskr Laeger; 2012 Mar; 174(10):647-8. PubMed ID: 22395014
[TBL] [Abstract][Full Text] [Related]
26. Question 2 Should a child with ADHD and epilepsy be given ritalin?
Boyes C
Arch Dis Child; 2010 Sep; 95(9):759-61. PubMed ID: 20716679
[No Abstract] [Full Text] [Related]
27. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
28. Methylphenidate euphoria.
Corrigall R; Ford T
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
[No Abstract] [Full Text] [Related]
29. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
Blom JD; Kooij JJ
Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
[TBL] [Abstract][Full Text] [Related]
30. Attention deficit hyperactivity disorder: part III.
Ryan-Krause P
J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
[No Abstract] [Full Text] [Related]
31. Intranasal abuse of prescribed methylphenidate.
Garland EJ
J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):573-4. PubMed ID: 9628076
[No Abstract] [Full Text] [Related]
32. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder.
Somoza EC; Winhusen TM; Bridge TP; Rotrosen JP; Vanderburg DG; Harrer JM; Mezinskis JP; Montgomery MA; Ciraulo DA; Wulsin LR; Barrett JA
J Addict Dis; 2004; 23(1):77-92. PubMed ID: 15077842
[TBL] [Abstract][Full Text] [Related]
33. Treatment of attention-deficit-hyperactivity disorder.
Elia J; Ambrosini PJ; Rapoport JL
N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
[No Abstract] [Full Text] [Related]
34. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
Durst R; Rebaudengo-Rosca P
Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
[TBL] [Abstract][Full Text] [Related]
35. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
36. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder.
Thompson J; Thompson JR
J Emerg Med; 2010 Jan; 38(1):18-21. PubMed ID: 18024065
[TBL] [Abstract][Full Text] [Related]
37. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
[TBL] [Abstract][Full Text] [Related]
38. Explosive outbursts associated with methylphenidate.
Adrian N
J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
[No Abstract] [Full Text] [Related]
39. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
40. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
